New Thought Leader for Agilent

Skip to Navigation

Blog Post

  • Published: Nov 21, 2017
  • Author: separationsNOW
  • Source: Agilent Technologies
  • Suppliers: Agilent Technologies
  • Channels: Ion Chromatography / Sample Preparation / HPLC / Detectors / Laboratory Informatics / Electrophoresis / Gas Chromatography / Proteomics & Genomics / X-ray Spectrometry / MRI Spectroscopy / Atomic / Chemometrics & Informatics / Proteomics / Infrared Spectroscopy / Raman / NMR Knowledge Base / UV/Vis Spectroscopy / Base Peak

View comments on this post

Agilent Technologies has presented its latest Thought Leader Award to Jiandong Jiang, director of the Institute of Materia Medica (IMM), Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) in Beijing, China, in support of his studies on cancer stem cells differentiation induced by natural products. Agilent's Thought Leader program promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences and chemical analysis.

“Cancer is a chronic disease generated by multiple factors. Our research is focused on the treatment of cancers with new concepts or principles, using cutting-edge techniques,” said Jiang, who is also the vice-chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA). Jiang’s research focuses on antimicrobial drugs, including viruses and bacteria, anticancer drugs, and the development of treatments for metabolic syndrome.

The Agilent Thought Leader Award will allow Jiang’s team to implement metabolite flux analyses, metabolism analyses and integrated biology approaches to characterize the anti-tumor activity of natural products. In addition to Agilent mass spectrometry solutions, Jiang’s lab will also make extensive use of Agilent Seahorse XF technology, and Agilent MassHunter and VistaFlux software. The project will also include a collaboration with Wenbin Li from the Beijing Shijitan Hospital, Capital Medical University, to perform clinical-related research.

“Agilent is proud to continue its support of cancer research with the use of our mass spectrometry systems, bioinformatics software, and metabolic analysis tools to facilitate the identification and characterization of cancer drugs,” said Victor Chan, Agilent vice president, and general manager of laboratory solutions for Agilent Greater China.

(Photo of Jiandong Jiang courtesy of the Institute of Materia Medica.)


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in separation science? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved